Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Depreciation & Amortization (CF): 2013-2024

Historic Depreciation & Amortization (CF) for Wave Life Sciences (WVE) over the last 12 years, with Dec 2024 value amounting to $3.9 million.

  • Wave Life Sciences' Depreciation & Amortization (CF) fell 9.70% to $856,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year decrease of 13.83%. This contributed to the annual value of $3.9 million for FY2024, which is 22.00% down from last year.
  • Wave Life Sciences' Depreciation & Amortization (CF) amounted to $3.9 million in FY2024, which was down 22.00% from $5.0 million recorded in FY2023.
  • In the past 5 years, Wave Life Sciences' Depreciation & Amortization (CF) registered a high of $8.1 million during FY2020, and its lowest value of $3.9 million during FY2024.
  • In the last 3 years, Wave Life Sciences' Depreciation & Amortization (CF) had a median value of $5.0 million in 2023 and averaged $5.2 million.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first increased by 6.76% in 2020, then declined by 24.24% in 2023.
  • Yearly analysis of 5 years shows Wave Life Sciences' Depreciation & Amortization (CF) stood at $8.1 million in 2020, then fell by 7.57% to $7.5 million in 2021, then dropped by 12.00% to $6.6 million in 2022, then dropped by 24.24% to $5.0 million in 2023, then dropped by 22.00% to $3.9 million in 2024.